This September 21, we call for more research and visibility to change the social consideration of the disease through the action "4lzh31m3r: the numbers to forget"
A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over five years.
The research center of the Pasqual Maragall Foundation has made the first visit of the EAPP study in July 2023.
According to the data presented, and simultaneously published in JAMA, the treatment with donanemab will significantly reduce the levels of amyloid plaque.
Among the most prominent research centers in Spain is the Barcelonaβeta Brain Research Center (BBRC) of the Pasqual Maragall Foundation.
During the meeting, the teams will disseminate their research findings to the international scientific community.
In order to know the situation of the drug in Europe, it will be necessary to wait for the resolution of the European Medicines Agency.
The document collects the most outstanding annual information on the scientific, social and economic activity of the two entities.
The program includes a day at the BBRC facilities, in which attendees will carry out a practical session on protein detection in organoid tissue.